Lead the design, oversight and project management of clinical development (phase II and Phase III clinical studies) of a diagnostic radio-pharmaceutical, as part of Gliomark, an EU Horizon 2020 SME-instrument phase 2 -funded project. Provide input in all pillars of the project, especially re Regulatory development and Communication/ Exploitation.

Mapped Medical Experts throughout Greece. Set-up and executed scientific & medical activities during the pre-launch and launch of Omalizumab in Chronic Spontaneous Urticaria and the pre-launch of Secukinumab in Psoriasis. Major accomplishments: increased KOL advocacy through strategic development plan implementation; as a member of the Brand-Team, established strong professional relationships with other team members to ensure smooth cooperation to co-develop & -deliver scientific events; fine-tuned product strategy by providing insights from the field based on external customers' medical needs.

Provided first-line medical interphase with Scientific Leaders for Remicade in Gastroenterology and Dermatology and for the prelaunch of Simponi in Rheumatology and Ulcerative Colitis. Major accomplishments: strengthened products' medical benefits and enhanced awareness by establishing strong peer-to-peer professional relationships with Scientific Leaders; established in-depth scientific knowledge for all team-members by delivering high-quality training to Marketing and Sales; effectively took over the Medical Affairs Manager's responsibilities – including preparation of annual Medical Affairs Plan, review of all Marketing-created physician-related materials and oversight of phase IV clinical research projects in various development phases – during two 6-month periods of maternity leave.

Responsible for site feasibility, site set up – including file preparation and submission to authorities and sites’ training on protocol & procedures – and monitoring of large phase III trials in over 15 sites across Greece. Participation to monthly alignment meetings with Medical colleagues.

Research topic: Toll-like Receptor function in the pathogenesis of sepsis in preterm neonates.Professor M. Xanthou

Research topic: Nuclear receptors of thyroid hormone as the pharmacological targets for the protection of the myocardium from ischemia. Professor D. Cokkinos, Assistant Professor K. Pantos

Research topic: The construction of several protein constructs and their expression analysis in fibroblastoid BHK21 cells by immunofluorescence. Department of Cellular Biology – Professor K. Simons